Published in Women's Health Weekly, May 27th, 2004
Their study was published in the May 1, 2004, issue of Clinical Cancer Research.
Antonio Giordano, MD, PhD, director of the Sbarro Institute and co-director of the Center for Biotechnology at Temple, and colleagues examined 45 primary ovarian carcinoma samples and found that 40% had a decrease or complete loss of Rb2 protein expression. Giordano discovered the Rb2 gene while working at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.